Trials / Completed
CompletedNCT00199537
Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (actual)
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Academic / Other
- Sex
- Male
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
Patients with advanced prostate cancer undergoing adjuvant treatment with androgen blockade will be followed over a 1 year interval to assess the effects of this treatment on bone metabolism. It is expected that men undergoing androgen blockade will experience accelerated bone loss.
Conditions
Timeline
- Start date
- 2005-02-01
- Primary completion
- 2008-02-01
- Completion
- 2008-02-01
- First posted
- 2005-09-20
- Last updated
- 2008-07-29
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00199537. Inclusion in this directory is not an endorsement.